The diffuse parenchymal lung diseases encompass
|
|
- Bethanie Byrd
- 6 years ago
- Views:
Transcription
1 Familial Idiopathic Interstitial Pneumonia Histopathology and Survival in 30 Patients Kevin O. Leslie, MD; Carlyne D. Cool, MD; Thomas A. Sporn, MD; Douglas Curran-Everett, PhD; Mark P. Steele, MD; Kevin K. Brown, MD; Momen M. Wahidi, MD; David A. Schwartz, MD N Context. Familial idiopathic interstitial pneumonia (F-IIP) describes the unexplained occurrence of diffuse parenchymal lung disease in related individuals. Prevailing wisdom suggests that the histopathology of F-IIP is indistinguishable from that of idiopathic pulmonary fibrosis, namely, usual interstitial pneumonia (UIP). Objective. To define the histopathology of F-IIP in lung tissue samples. Design. Tissue sections from 30 patients with F-IIP, enrolled in a national research program, were evaluated by 3 pulmonary pathologists using 15 predefined histopathologic features. Each feature was recorded independently before a final diagnosis was chosen from a limited list dichotomized between UIP or not UIP. These 2 groups were then compared to survival. Results. The consensus diagnosis for the F-IIP cohort was an unclassifiable parenchymal fibrosis (60%), with a high incidence of histopathologic honeycombing, fibroblast foci, and smooth muscle in fibrosis. Usual interstitial pneumonia, strictly defined, was identified in less than half of the F-IIP cases (range, 23% 50%). Interobserver agreement was fair (k = 0.37) for 2 observers for the overall diagnosis of UIP. Findings unexpected in UIP were prevalent. The survival for the entire F-IIP cohort was poor, with an estimated mortality of 93% and a median age at death of 60.9 years. Subjects with UIP had a shorter survival and younger age at death. Conclusions. Pulmonary fibrosis was the dominant histopathology identified in our patients, but diagnostic features of UIP were seen in less than 50% of the samples. Overall survival was poor, with mortality accelerated apparently by the presence of a UIP pattern of disease. (Arch Pathol Lab Med. 2012;136: ; doi: /arpa OAI) The diffuse parenchymal lung diseases encompass a broad spectrum of predominantly nonneoplastic inflammatory conditions that preferentially involve the lung interstitium (often referred to clinically as interstitial lung diseases ). These conditions can be related to infection, a variety of inhaled or systemic exposures, systemic autoimmune disease, and even neoplasms. 1 3 A subset of diffuse Accepted for publication January 18, From the Department of Pathology, Mayo Clinic Arizona, Scottsdale (Dr Leslie); the Departments of Pathology (Dr Cool) and Medicine (Dr Schwartz), University of Colorado School of Medicine, Aurora; the Department of Pathology, Division of Pathology Clinical Services (Dr Sporn) and Division of Pulmonary, Allergy, and Critical Care Medicine (Drs Steele and Wahidi), Duke University Medical Center, Durham, North Carolina; the Division of Biostatistics and Bioinformatics (Dr Curran-Everett) and the Department of Medicine (Dr Brown), National Jewish Health, Denver, Colorado. Travel and accommodation expenses to Denver, Colorado, for case review were supported by a grant from the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes for Health and Duke University Medical Center, Durham, North Carolina (T.A.S.) and by Mayo Clinic Arizona, Scottsdale (K.O.L.). Statistical support for Mayo Clinic statisticians (Amylou Dueck, PhD, and Yu-Hui Chang, PhD) was provided by Mayo Clinic Arizona, Scottsdale. The authors have no relevant financial interest in the products or companies described in this article. This study was presented in part at the biennial meeting of the Pulmonary Pathology Society, Annecy, France, June 16, Reprints: Kevin O. Leslie, MD, Department of Pathology, Mayo Clinic Arizona, East Shea Blvd, Scottsdale, AZ ( Leslie. Kevin@mayo.edu). lung diseases has no identifiable etiology despite a comprehensive evaluation and is referred to as the idiopathic interstitial pneumonias (IIPs). By international multidisciplinary consensus, the IIPs include the clinical disorders of idiopathic pulmonary fibrosis (IPF), cryptogenic organizing pneumonia, respiratory bronchiolitis associated interstitial lung disease/desquamative interstitial pneumonia, lymphoid interstitial pneumonia, and acute interstitial pneumonia. 4 Kindred associations have been described for diffuse lung diseases of both known and unknown (idiopathic) etiology, strongly implicating a heritable genetic influence in affected individuals. The reported conditions include sarcoidosis, 5 a variety of rheumatic diseases, 6 9 lymphangioleiomyomatosis, 10 the Hermansky-Pudlak syndrome 11 neurofibromatosis, 12 and familial hypercalcemic hypocalciuria. 13 The most commonly described genetic predisposition in diffuse lung disease is for a familial form of IPF The occurrence of IPF in large family kindreds as well as in twins 18 adds further support for a yet-to-be identified genetic predisposition to chronic, particularly fibrosing, interstitial lung disease. Nevertheless, recent evidence suggests considerable pathologic diversity in F-IIP. In 2005, Steele et al 19 reported on the largest study of familial interstitial pneumonia from the United States (111 families having 2 or more affected family members) in which 45% of the pedigrees demonstrated features of more than 1 histopathologic subtype of IIP. In this study, ever tobacco smoking was associated with risk of disease, suggesting 1366 Arch Pathol Lab Med Vol 136, November 2012 Pathology of Familial Idiopathic Interstitial Pneumonia Leslie et al
2 Table 1. Features Studied and Rationale for Inclusion Histopathologic Feature Rationale for Inclusion 1. Air space organization A marker of organizing acute lung injury, organizing infectious pneumonia, toxic drug reaction, autoimmune diseases manifesting in the lung, cryptogenic organizing pneumonia 2. Alveolar macrophages Obstructive diseases, drug reactions, respiratory bronchiolitis, smoking-related interstitial disease (respiratory bronchiolitis associated interstitial lung disease, desquamative interstitial pneumonia, pulmonary Langerhans cell histiocytosis) 3. Bronchiolitis Postinfectious bronchiolitis, smoking related (respiratory bronchiolitis), aspiration, connective tissue diseases, hypersensitivity pneumonitis, immunoglobulin deficiency 4. Eosinophils Interstitial: smoking and eosinophilic pneumonia Intra-alveolar: eosinophilic pneumonia, infections 5. Peribronchiolar fibrosis Chronic aspiration, pulmonary Langerhans cell histiocytosis, chronic hypersensitivity pneumonitis, idiopathic airway-centered scarring 6. Smooth muscle hyperplasia in fibrosis Usual interstitial fibrosis, fibrotic nonspecific interstitial pneumonia 7. Diffuse alveolar septal fibrosis Fibrotic nonspecific interstitial pneumonia, various connective tissue diseases, toxic drug reactions, chronic hypersensitivity pneumonitis 8. Subpleural, peripherally accentuated This pattern requires spared lung more centrally in lobules and, combined with fibroblast fibrosis foci, is a surrogate for the temporal heterogeneity of usual interstitial pneumonia 9. Fibroblast foci Usual interstitial pneumonia, fibrotic nonspecific interstitial pneumonia, chronic hypersensitivity pneumonitis 10. Microscopic honeycombing Usual interstitial pneumonia, collagen vascular diseases, any severe localized injury 11. Pleuritis General marker for collagen vascular diseases 12. Interstitial chronic inflammation Hypersensitivity pneumonitis, viral infections, nonspecific interstitial pneumonia, drug toxicity, rheumatic diseases 13. Vascular adventitial thickening Adventitia of greater thickness than the media, in arteries less than 200 mm in diameter, suggests systemic connective tissue diseases (C.D.C., unpublished data, 2002) 14. Squamous metaplasia of terminal airways Evidence for subacute reparative reaction 15. Reactive type II cells A marker for ongoing injury with epithelial repair that both genetic and environmental factors may influence the type of lung disease that supervenes in these families. When using this US cohort to conduct a genome-wide search for susceptibility alleles by linkage analysis, followed by association-based fine mapping, a single nucleotide polymorphism (SNP) in the promoter region of MUC5B was shown to increase the risk of developing pulmonary fibrosis among family members, by 6-fold if heterozygous for the SNP and by 22-fold if homozygous. Similar increased risk of disease was identified in sporadic cases of idiopathic pulmonary fibrosis with the MUC5B SNP. 14 Despite studies emphasizing considerable heterogeneity of disease in F-IIP, many investigators still hold on to the concept that the histopathology of F-IIP is indistinguishable from that seen in idiopathic pulmonary fibrosis. 14,17,20 No rigorous study has yet focused on the specific pathologic attributes of F-IIP, using predefined pathologic criteria and independent slide review by more than 1 pathologist. In our study, 3 experienced pulmonary pathologists evaluated lung tissue samples from 30 subjects with F-IIP for the presence, distribution, and severity of individual histopathologic features and then rendered an overall diagnostic impression dichotomized first between usual interstitial pneumonia (UIP) or not UIP. predicted; SD, 16.71). Each subject had a definite clinical diagnosis of IIP with the criteria established by the American Thoracic Society and the European Respiratory Society. 4 All tissue slides for each subject were deidentified and assigned a subject number before analysis. Selection of Histopathologic Features Fifteen histopathologic features were chosen for study (Table 1 and Figure 1, A through O). Four were selected by their common occurrence in UIP as it is diagnosed today and further validated by current international multidisciplinary consensus (peripheral lobular accentuation of fibrosis, histopathologic honeycombing, fibroblast foci, and smooth muscle proliferation in dense fibrosis). 4 The remaining 11 features were chosen as potential markers of other forms of IIP. 4 All 15 variables were evaluated first for their presence or absence (primary descriptor), followed by 1 or more secondary descriptors related to extent, intensity, and cellular composition, as appropriate. For each case, 31 total descriptors were evaluated. Each pathologist was asked to collect data on all of the individual findings from the biopsy sections before rendering a global pathologic pattern diagnosis from a predefined list (.900 individual observations for each pathologist throughout the course of the study) (Table 2). We purposely did not include any non-uip IIP diagnoses (eg, lymphoid interstitial pneumonia, nonspecific interstitial pneumonia [NSIP]) in the not-uip list of global diagnosis choices given our a priori desire to collect objective descriptions of the dominant histopathologic findings for the not-uip group. MATERIALS AND METHODS Study Patients With F-IIP Thirty lung tissue specimens (29 surgical lung biopsies and 1 autopsy specimen) were randomly selected from a large cohort of familial interstitial pneumonia patients who had complete phenotype data including medical history, diffusing capacity for carbon monoxide (DLCO), chest computed tomography, and availability of lung tissue blocks. 19 The 30 patients had a mean age of years (median, 51 years; SD, 11.22) and represented 21 separate pedigrees. Sex was equally divided and the cohort was predominantly white (27 white, 1 Hispanic, 2 unknown). The mean DLCO at presentation was 43.75% predicted (median, 41% Pretest Training A booklet of data collection sheets was created for each of the study pathologists for use during a pretest training session. These booklets included high-resolution color photomicrographs illustrating each parameter to be evaluated, along with images demonstrating semiquantitative aspects of the feature (eg, mild bronchiolitis versus moderate bronchiolitis). All 3 reviewers met over a multiheaded microscope where the data sheets were discussed in the context of a random set of IIP surgical biopsies. Data Collection Three reviewers independently collected observations on each subject s biopsy slides and entered them in specially Arch Pathol Lab Med Vol 136, November 2012 Pathology of Familial Idiopathic Interstitial Pneumonia Leslie et al 1367
3 Figure 1. Histopathologic features evaluated. A, Peripheral lobular accentuation of fibrosis: This feature is a subcomponent of temporal heterogeneity and is a reproducible feature seen in usual interstitial pneumonia, as it corresponds to clinical sporadic idiopathic pulmonary fibrosis. The fidelity of this finding is variable in well documented cases of idiopathic pulmonary fibrosis, given nuances of biopsy selection site and biopsy size. The peripheral nature of this fibrosis pattern is evident in the surgical lung biopsy, as scar forms beneath pleura and extends along intralobular septa. In the area of lung surrounded by fibrosis, a central, or slightly eccentric, artery is typically present, often accompanied by its bronchiole. B, Histopathologic honeycombing: A hallmark histopathologic feature of advanced lung fibrosis with remodeling, histopathologic honeycombing is characterized by variably sized aggregated cysts containing mucin. The mucin often has neutrophils and the lining of the cyst is respiratory epithelium. C, Fibroblast foci: Fibroblast foci are required for a diagnosis of usual interstitial pneumonia but can be seen in other disorders. In this image, a single fibroblast focus is present overlying scarred parenchyma in the upper right portion of the image. The fibroblast focus is composed of myofibroblasts in parallel arrays with an immature myxoid stroma. Reactive type II cells can often be seen over the surface of the fibroblast focus. D, Alveolar 1368 Arch Pathol Lab Med Vol 136, November 2012 Pathology of Familial Idiopathic Interstitial Pneumonia Leslie et al
4 Figure 2. Findings in familial idiopathic interstitial pneumonia (F-IIP) cases showing usual interstitial pneumonia. A and B, Temporal heterogeneity was present in a subset of the F-IIP cases, but often with less definable peripheral lobular accentuation. Histopathologic honeycombing (hh) was a finding in nearly all of the cases. C, Smooth muscle (sm) proliferation in dense scar was common. D, Fibroblast foci (arrows) were encountered frequently (hematoxylin-eosin, original magnifications 320 [A and C] and 340 [B and D]). prepared booklets. The booklets had data collection sheets for each parameter, identical to the ones used in pretest training except for the use of black-and-white photographs as a reminder of the histopathologic parameter being assessed. There was wide variability in the number of tissue slides available for each surgical biopsy (1 to.10). In cases with multiple slides (potentially representing more than 1 biopsy sample, as all slides for a given subject were assigned a single unique identifier), all r macrophages: Alveolar macrophages were assessed by quantitative and qualitative features. This image shows a dense aggregation of intra-alveolar macrophages with mixed clear vacuolated and densely eosinophilic cytoplasm. E, Peribronchiolar metaplasia: This image demonstrates 3 cross sections of pulmonary artery surrounded by irregular, incomplete small airway profiles. This finding is a feature of chronic airway-centered pathology. F, Diffuse septal fibrosis: Alveolar wall fibrosis with some fusion, but overall preservation of structure, is a feature ascribed to nonspecific interstitial pneumonia. G, Chronic bronchiolitis: Chronic bronchiolitis is a sign of chronic airway inflammatory disease. This image demonstrates a bronchiole surrounded by lymphoid cells and a lymphoid aggregate at right center. H, Pleural inflammation: The presence of acute or chronic pleuritis was assessed as a potential marker for systemic autoimmune disease. The surface in this image shows fibrin and reactive mesothelial cells overlying lung parenchyma with mild interstitial fibrosis. I, Interstitial chronic inflammation: Chronic inflammation of the alveolar walls is a sign of inflammatory lung disease when present in significant amounts. J, Vascular adventitial fibrosis: Thickening of the vascular adventitia with collagen (arteries,200 mm in diameter) seems to correlate with the presence of systemic autoimmune disease. The definition of this feature is adventitia thickness exceeding muscle wall thickness (.1:1 ratio). In this study 10 small pulmonary artery branches in cross section were evaluated for each case and the number for which thickness of adventitia exceeded that of muscularis was tabulated. K, Squamous metaplasia of terminal airways: Squamous metaplasia is a sign of subacute airway injury. L, Reactive type II cell hyperplasia: Reactive type II cell hyperplasia is a phenomenon related to lung injury and repair. M, Eosinophils in lung parenchyma: Presence of eosinophils in alveoli or interstitium was assessed as a potential marker for eosinophilic lung disease. N, Air space organization: Air space organization is a sign of subacute lung injury. This feature was assessed for presence and extent. O, Smooth muscle hyperplasia in scar: Smooth muscle proliferation in established scar is a characteristic finding seen in usual interstitial pneumonia (hematoxylin-eosin, original magnifications 320 [A], 340 [B, F, and I], 3200 [C, E, J, K, M, N, and O], 3600 [D], 3100 [G and H], and 3400 [L]). Arch Pathol Lab Med Vol 136, November 2012 Pathology of Familial Idiopathic Interstitial Pneumonia Leslie et al 1369
5 Table 2. Data Collection Form Chronic fibrosing IP with honeycombing, consistent with UIP or Findings NOT typical of UIP 1. Acute IP with hyaline membranes 2. Acute IP, NOS 3. Acute IP, favor eosinophilic pneumonia 4. Chronic IP, unclassified 5. Chronic IP, favor HP 6. Chronic IP, favor EP 7. Chronic fibrosing IP, unclassified 8. Chronic fibrosing IP with honeycombing, unclassified 9. Acute and chronic IP, unclassified 10. Honeycomb lung only Abbreviations: EP, eosinophilic pneumonia; HP, hypersensitivity pneumonitis; IP, interstitial pneumonia; NOS, not otherwise specified; UIP, usual interstitial pneumonia. slides were reviewed in assessing the individual features and arriving at an overall histopathologic pattern diagnosis. Establishing Observer Consensus To control for variability between observers, during the analysis phase of the study, a consensus result was established for every histopathologic feature when 2 or more observers were in agreement. For fibroblast foci and vascular adventitial thickening, for which data entries were numerical, an average was determined. For secondary features, if all 3 reviewers chose different values, the result was entered as no consensus. If any parameter had only 1 data entry, the result was entered as no consensus. If consensus of 2 reviewers determined that a variable was absent, entries for the third reviewer s related modifier features were considered not applicable. Statistical Analysis Agreement for the pathology reviewers interpretations of the primary descriptor variables was estimated by Cohen k coefficient.21 A nonparametric test was applied to survival, given the relative small sample size in the 2 comparison groups (non UIP 5 17; UIP 5 11). Age at death was evaluated for the entire cohort and was compared between groups by using the Wilcoxon rank-sum test. RESULTS Histopathologic Patterns (Features) in F-IIP The consensus results for all parameters are presented in Table 3. The UIP morphologic pattern, defined as the co-occurrence of peripheral lobular accentuated fibrosis with temporal heterogeneity, histopathologic honeycombing, fibroblast foci, and smooth muscle proliferation in dense peripheral lobular fibrosis (Figure 2, A through D), was present in the F-IIP cohort, but the complete pattern was judged to be present by the individual reviewers in 23% to 50% of the cases. Figure 3. Other patterns of fibrosis in familial idiopathic interstitial pneumonia. A, Homogeneous interstitial fibrosis resembling nonspecific interstitial pneumonia. B, Areas of interstitial fibrosis with abundant chronic inflammation. C, Areas with some airway-centered scarring but lacking granulomas or multinucleated giant cells of chronic hypersensitivity pneumonitis. D, Coarse interstitial fibrosis with mild siderosis (hematoxylineosin, original magnifications 320 [A and C] and 340 [B and D]) Arch Pathol Lab Med Vol 136, November 2012 Pathology of Familial Idiopathic Interstitial Pneumonia Leslie et al
6 Figure 4. Kaplan-Meier survival curves comparing usual interstitial pneumonia (UIP) (A) and not-uip (B) cases. Abbreviations: Min., minimum; Max., maximum; Pctl, percentile; StdDev, standard deviation. For the 17 not-uip cases, all but 1 case fell within the spectrum of unclassifiable pulmonary fibrosis (Table 3, footnote a ). Some cases might be considered forms of NSIP, except for the high prevalence of histopathologic honeycombing (unexpected in NSIP). 4,22,23 Example images from the not-uip cases are presented in Figure 3, A through D. The most commonly identified individual features in the F-IIP biopsy specimens are presented in Table 4. Interobserver Variability Considerable variability was identified between pathologists for the 15 primary variables, and more dramatically, for the descriptor variables. This diversity was not unexpected given the subjective nature of the observations and the high prevalence of advanced fibrosis and remodeling. Disagreement between pathologists regarding the presence or absence of 1 or more features was present to a variable degree in every case. The k scores for combinations of reviewers, regarding several major features, are presented in Table 5. For the global assessment of UIP or not UIP, a k score of 0.37 was achieved, for 2 observers, consistent with fair interobserver agreement. 21 Among the UIP-associated features, agreement was greatest for the presence or absence of fibroblast foci (0.71), subpleural fibrosis (0.64), and histopathologic honeycombing (0.45) and least for smooth muscle hyperplasia (0.07). Survival Data Survival for our study cohort was poor, with 28 of 30 subjects deceased (mortality of 93%), a mean age of death of 55 years, and a median age of death of 60.9 years. This may be in part a reflection of the very low mean DLCO values for the group, obtained by pulmonary function studies performed at the time of subject identification. Sixteen of 28 deaths resulted from respiratory failure caused by chronic pulmonary disease (57%), although this figure may be a low estimate, given missing data on specific cause of death in 12 of 28. There was a single surviving patient in each of the UIP and not-uip groups. The age at death was significantly younger in the UIP pattern group, with a median age of 51.0 years for patients with a UIP pattern and 64.1 years for those with a pattern of not UIP (P 5.03), indicating that the UIP pattern is associated with a decreased relative survival by 10 years. Kaplan-Meier survival curves comparing these 2 groups are presented in Figure 4, A and B. COMMENT The exact prevalence of familial forms of IIP is uncertain. Previously, familial forms of IIP were thought to be rare, 24 although descriptions have appeared in the literature since Over the years, several case reports and clinical studies have described individual patients and small clinical series of familial diffuse lung disease (61 probands in total). On the basis of published accrual methods, most study subjects were identified through 1 or more index case(s) in which other family members had unexplained lung disease or through prospective national searches for kindred-linked lung disease ,20,26 29 In our study, we were able to dismiss the prevailing hypothesis that all subjects with F-IIP have histopathology Arch Pathol Lab Med Vol 136, November 2012 Pathology of Familial Idiopathic Interstitial Pneumonia Leslie et al 1371
7 Case No. UIP Non-UIP Diagnosis a Table 3. Alveolar Organization Consensus Histopathologic Features Alveolar Macrophage Extent, % Bronchiolitis Smooth Muscle Distribution Estimate Type b Grade Type Hyperplasia Distribution 1 No 7 No No NA NA No NA Yes Mod 2 No 9 Confl Rare,25 1,3 No NA Yes Mld 3 No 8 No No NA NA Mod Foll No NA 4 No 10 No No NA NA No NA Yes Mod 5 No 10 No No NA NA No NA Yes Mod 6 No 8 No Rare No NA Yes Mld 7 No 8 No Mult Mld Cell No NA 8 No 7 Mult Rare,25 1 Mld Cell Yes Mld 9 No 7 No Confl.50 1 No NA Yes Mld 10 No 10 No Rare,25 1 No NA Yes Mld 11 No 8 Rare Rare,25 3 Mld Cell Yes Mld 12 No 7 Rare Rare,25 1 Mld Cell Yes Mld 13 No 8 No Rare,25 1,3 Mld Cell Yes Mld 14 No 8 No Rare,25 1 No NA Yes Mld 15 No 10 No No NA NA No NA Yes Mod 16 No 8 No Rare,25 1,3 Mld Cell Yes Mld 17 No 7 Mult Mult Mld Cell Yes Mld 18 No 10 No No NA NA No NA Yes Mld 19 Yes Rare Rare,25 1 Mld Cell Yes Mld 20 Yes No Mult,25 3 No NA Yes Mld 21 Yes No Mult Mld Cell Yes Mld 22 Yes Mult Rare ,3 No NA Yes Mod 23 Yes No Rare,25 1 Mld Cell Yes Mld 24 Yes No Mult,25 1,2 Mld Cell Yes Mod 25 Yes Rare Mult Mld Cell Yes Mld 26 Yes Rare Rare Mld Cell Yes Mod 27 Yes No Rare,25 1 Mld Cell Yes Mld 28 Yes No Rare,25 1 Mld Cell Yes Mld 29 Yes Rare Rare,25 1 Mod Cell Yes Mod 30 Yes No Confl.50 2 Mld Cell Yes Sev Abbreviations: Cell, cellular; Chr, chronic; Confl, confluent; Diff, diffuse; Foc, focal; Foll, follicular; Gd, good; Inter, interstitial; Marg, marginal; Mld, mild; Mod, moderate; Mult, multifocal; NA, not applicable; No, none; Sev, severe; UIP, usual interstitial pneumonia; NC, no concensus. a 7 5 Chronic fibrosing interstitial pneumonia, unclassifed; 8 5 Chronic fibrosing interstitial pneumonia with honeycomb, unclassified; 9 5 Acute and chronic interstitial pneumonia, unclassified; 10 5 Honeycombing only. b 15 Eosinophilic; 2 5 Siderotic; 3 5 Vacuolated; 4 5 Mixed. c Focal to confluent. Numbers are an average of 3 reviewers9 input. d No. thickened in 10 vessels. Numbers are an average of 3 reviewers9 input. indistinguishable from sporadically occurring IPF, namely, usual interstitial pneumonia. Most of our patients had individual histopathologic features commonly associated with UIP, but most of our study subject lung biopsies would not qualify for inclusion in clinical trials targeting IPF today. Many different mechanisms of injury to the lung can result in advanced lung remodeling with fibrosis. Usual interstitial pneumonia, as defined today, is a distinctive form of pulmonary fibrosis characterized by the critical presence of so-called temporal heterogeneity, implying the coexistence of advanced microscopic fibrosis (with destruction of alveolar architecture) and uninvolved lung in the same biopsy section. This arrangement of fibrosis at the microscopic level produces a variegated appearance to the biopsy section at scanning magnification. Focal proliferations of immature fibroblasts covered by reactive type II pneumocytes (fibroblast foci) can be seen at the interface between fibrosis and preserved lung. Fibroblast foci are considered to be the leading edge of ongoing injury in UIP and are required to be present for diagnosis. However, fibroblast foci are not unique to UIP and occur in such disparate conditions as NSIP and recurrent pneumothorax in otherwise young, healthy individuals. Importantly, identification of only 1 of these expected findings is not sufficient for a diagnosis of the UIP pattern in current practice. 30 To add stringency to the histopathologic assessments in this study, each reviewer was asked to identify the presence or absence of individual histopathologic features as an initial part of the slide evaluation. Once these were recorded, each reviewer then chose a global histopathologic assessment from a list of choices dichotomized by whether the overall pattern was UIP or not UIP. Using current international multidisciplinary criteria, 60% of our F-IIP cases did not qualify as UIP, mainly because of a lack of temporal heterogeneity. Their biopsy findings were felt to represent a form of unclassifiable fibrotic lung disease. Whether or not this is biopsy selection bias or a true manifestation of the underlying pathologic process is impossible to judge accurately, given the inherent constraints of the study material (eg, mostly advanced disease being sampled). Importantly, cases having this unclassified fibrosis frequently had other changes that would reasonably argue against a UIP diagnosis, such as diffuse alveolar septal fibrosis resembling NSIP, multifocal peribronchiolar fibrosis, and/or diffuse chronic inflammation in the alveolar parenchyma. None of our study patients had granulomas in their biopsy results. The 1372 Arch Pathol Lab Med Vol 136, November 2012 Pathology of Familial Idiopathic Interstitial Pneumonia Leslie et al
8 Table 3. Consensus Histopathologic Features Extended. Septal Fibrosis Peripheral Lobular Accentuation Fibroblast Microscopic Honeycombing Pleuritis Case No. Distribution Diffuse Grade Extent Fidelity Focus Extent c Foci Fidelity Extent Fidelity Extent Type 1 No Mld Diff Gd 1.6 Gd Foc Gd No NA 2 No Mod Foc +/2 0.6 OK Foc OK No NA 3 Diff Mod No NA 0.0 NA Foc OK Foc Chr 4 No NA No NA 0.6 OK Diff Gd No NA 5 No NA No NA 0.5 OK Diff Gd No NA 6 Foc Mld Foc OK 1.6 OK Foc OK No NA 7 Diff Mod Foc Gd 1.3 OK Foc Marg No NA 8 Foc Mld Diff OK 2.6 OK Foc Marg Foc Chr 9 Diff Mod No NA 0.0 NA No NA No NA 10 No NA No NA 0.0 NA Diff Gd Diff Chr 11 Diff Sev No NA 4.0 OK Diff Gd Foc Chr 12 Foc Mod No NA 2.3 Gd No NA No NA 13 Diff Mod No NA 1.3 Marg Foc Marg No NA 14 Diff Mod No NA 1.3 Marg Foc Gd Foc Chr 15 No NA No NA 1.6 OK Diff Gd Foc Chr 16 Diff Sev Diff OK 4.0 OK Foc OK No NA 17 Foc Mod No NA 1.3 NA No NA No NA 18 No NA No NA 0.0 NA Diff Gd Foc Chr 19 Foc Mld Diff Gd 2.3 Gd Foc Gd Foc Chr 20 Foc Mod Foc OK 1.6 OK Foc Gd No NA 21 Diff Mod Foc OK 2.3 Gd Foc Gd Foc Chr 22 Diff Mld Diff Gd 3.3 OK Foc Gd Foc Chr 23 Diff Mld Diff OK 2.6 OK Foc OK No NA 24 Diff Mod Foc OK 3.3 Gd Foc Gd Foc Chr 25 No NA Foc NA 2.6 Gd Foc OK No NA 26 Foc Sev Diff Gd 3.3 Gd Foc Gd No NA 27 Foc Mod Foc Gd 3.0 Gd Foc Gd Foc Chr 28 Foc Mld Foc Gd 3.3 Gd Foc Marg Foc Chr 29 Foc Mod Diff Gd 2.0 Marg Foc Gd Foc Chr 30 Diff Mod Foc OK 3.6 Gd Foc Gd Foc Chr Abbreviations: Cell, cellular; Chr, chronic; Confl, confluent; Diff, diffuse; Foc, focal; Foll, follicular; Gd, good; Inter, interstitial; Marg, marginal; Mld, mild; Mod, moderate; Mult, multifocal; NA, not applicable; No, none; Sev, severe; UIP, usual interstitial pneumonia; NC, no concensus. a 7 5 Chronic fibrosing interstitial pneumonia, unclassifed; 8 5 Chronic fibrosing interstitial pneumonia with honeycomb, unclassified; 9 5 Acute and chronic interstitial pneumonia, unclassified; 10 5 Honeycombing only. b 15 Eosinophilic; 2 5 Siderotic; 3 5 Vacuolated; 4 5 Mixed. c Focal to confluent. Numbers are an average of 3 reviewers9 input. d No. thickened in 10 vessels. Numbers are an average of 3 reviewers9 input. frequent finding of non-uip pathologic features supports the observation of different types of IIP being identified within families, as reported by Steele et al. 19 The observation of both UIP and non-uip features among family members in their study supports the hypothesis that multiple factors, genetic or environmental, determine the phenotype in a given individual. Given the potential permutations and substantial differences in observer opinion regarding the presence or absence of specific features (Table 3), it is not surprising that the breakdown by reviewer of UIP versus not UIP was variable (range, 23% 50%). To be fair, most of the lung specimens had significant fibrosis and no study to date has evaluated interobserver variability within a cohort for which difficult to classify lung fibrosis is the dominant pattern. Furthermore, none of the cases in our study had pathologic features entirely characteristic of an alternate idiopathic interstitial pneumonia, but some of the non-uip cases would have been reasonably classified as NSIP in at least some areas of the sections evaluated. The high prevalence of advanced histopathologic honeycombing remodeling in these cases limited our ability to assign this diagnosis. 22 Another interesting finding in our study was the occurrence of arterial adventitial fibrosis (. 1:1 ratio comparing media thickness to adventitia thickness involving small pulmonary arteries,200 mm in diameter) in 40% of our subjects. This parameter was included on the basis of unpublished data from one of the authors (C.D.C., verbal communication, 2002) of a relationship between this finding in lung biopsies and presence of a systemic autoimmune disease. Despite this implied relationship, none of the patients in this study had clinical manifestations, or serology findings, to suggest undiagnosed connective tissue disease. Additional histopathologic features (Table 3) that argued against a diagnosis of UIP were chronic bronchiolitis (60%), NSIP-like diffuse alveolar septal fibrosis with preservation of alveolar architecture (40%), peribronchial fibrosis (37%), diffuse chronic parenchymal inflammation (33%), and intra-alveolar eosinophils (27%). As might be expected, some of these features were also those most likely to be seen in patients with pulmonary fibrosis simulating UIP of IPF, namely, systemic autoimmune disorders (such as rheumatoid arthritis) and chronic hypersensitivity pneumonitis to inhaled organic antigen. Potential flaws in our study include biopsy sampling bias and the lack of radiologic correlation. Sampling bias could have played a definite role regarding a confident Arch Pathol Lab Med Vol 136, November 2012 Pathology of Familial Idiopathic Interstitial Pneumonia Leslie et al 1373
9 Table 3. Consensus Histopathologic Features Extended. Eosinophils Peribronchiolar Fibrosis Chronic Inflammation Vascular Adventitial Case No. Distribution Grade Fibrosis d Grade Location Present? Extent Distribution 1 Foc Mld 0.3 No NA Yes Mld Mult 2 Foc Mld 1.6 Mld Both Yes Mld Foc 3 Diff Mod 1.0 No NA Yes Mod Mult 4 Diff Mod 2.3 No NA No NA NA 5 Foc Mod 0.0 No NA No NA NA 6 Foc Mod 1.6 Mld Inter Yes Mld Foc 7 Foc Mod 3.0 No NA No NA NA 8 Foc Mld 1.6 Mod Inter Yes Mld Foc 9 Diff Mod 1.3 Mld Both No NA NA 10 Diff Mod 2.6 No NA No NA NA 11 Diff Mod 3.3 Mod Both Yes Mld Foc 12 Foc Mld 3.6 Mod Inter No NA NA 13 Diff Mld 2.3 Mld Inter Yes Mld Mult 14 Foc Mld 0.6 Mld Both Yes Mod Mult 15 Foc Mod 0.6 Mld Inter No NA NA 16 Foc Mld 3.6 Mld Inter Yes Mld Foc 17 Foc Mld 0.6 No NA Yes Mld Mult 18 Diff Mld 0.0 No NA No NA NA 19 Foc Mod 3.0 Mld Inter Yes Mld Mult 20 Foc Mld 2.0 Mld Inter Yes Mod Mult 21 Diff Mod 0.0 Mld Both Yes Mod Mult 22 Foc Mld 0.3 Mld Both No NA NA 23 Foc Mld 1.6 Mld Inter Yes Mld Foc 24 Foc Mod 2.6 Mld Inter Yes Mld Foc 25 Foc Mld 2.0 No NA Yes Mld Mult 26 Foc Mld 0.6 No NA Yes Mld Mult 27 Diff Mod 4.0 Mld Inter Yes Mld Mult 28 Foc Mld 0.6 Mld Inter No NA NA 29 Diff Mod 4.6 Mld Both No NA NA 30 Foc Mod 3.0 c Mld Both Yes Mld Foc Abbreviations: Cell, cellular; Chr, chronic; Confl, confluent; Diff, diffuse; Foc, focal; Foll, follicular; Gd, good; Inter, interstitial; Marg, marginal; Mld, mild; Mod, moderate; Mult, multifocal; NA, not applicable; No, none; Sev, severe; UIP, usual interstitial pneumonia; NC, no concensus. a 7 5 Chronic fibrosing interstitial pneumonia, unclassifed; 8 5 Chronic fibrosing interstitial pneumonia with honeycomb, unclassified; 9 5 Acute and chronic interstitial pneumonia, unclassified; 10 5 Honeycombing only. b 15 Eosinophilic; 2 5 Siderotic; 3 5 Vacuolated; 4 5 Mixed. c Focal to confluent. Numbers are an average of 3 reviewers9 input. d No. thickened in 10 vessels. Numbers are an average of 3 reviewers9 input. diagnosis of UIP, based on published data showing potential discordances between biopsy samples from different sites in the same patient (eg, one biopsy specimen showing UIP, while another did not). 31 We cannot exclude a similar sampling bias regarding our F-IIP biopsies. An independent assessment of radiologic imaging was not included as a parameter in our study, given our initial design as a pure assessment of histopathology. Interobserver Agreement The k score for the global assessment of UIP or not UIP was 0.37, consistent with fair interobserver agreement (range, ) for 2 observers. This finding is similar to that identified in a previous study of interstitial lung disease diagnosis by Nicholson et al, 32 in which specialist pathologists were participants. In their study, 10 experienced pulmonary pathologists evaluated independently a set of lung biopsy specimens representing a wide spectrum of diffuse parenchymal lung diseases. No clinical or imaging information was provided. The observers were asked to select from a list of defined acute and chronic diffuse lung diseases, including the IIPs. The k scores for the diagnosis of UIP were fair, similar to our results. Interestingly, the k scores were worst for the diagnosis of NSIP, underscoring the need for better criteria for this IIP and rigorous application of these during assessment. As one might expect, Nicholson et al 32 found that the k scores were significantly better for diagnoses having distinctive histopathologic attributes (eg, the granulomas of sarcoidosis). This effect is also evident in our study, where agreement on the presence of specific features, such as fibroblast foci, was quite good (Table 3). Among the UIP-associated features we evaluated, the highest k scores were obtained for the presence of fibroblast foci (k ) and the lowest, for the presence of smooth muscle hyperplasia in fibrosis (k ). This latter discordance may have been methodological, as the lower threshold for identifying this feature was never established (ie, how much is enough for including the presence of this finding). Survival of F-IIP Cohort Overall survival for this F-IIP cohort was poor (93% mortality by 10 years) and not unexpected given the high prevalence of advanced fibrosis with lung remodeling. Most deaths were attributable to respiratory failure from pulmonary disease, despite missing data on specific cause 1374 Arch Pathol Lab Med Vol 136, November 2012 Pathology of Familial Idiopathic Interstitial Pneumonia Leslie et al
10 Table 3. Consensus Histopathologic Features Extended. Case Squamous Metaplasia Reactive Type II No. Present? Extent Distribution Cells Extent 1 No NA NA Yes Foc 2 Yes Mld Foc Yes Mult 3 No NA NA Yes Foc 4 Yes Mld Foc No NA 5 No NA NA No NA 6 Yes Mld Foc Yes Mult 7 No NA NA No NA 8 No NA NA Yes Foc 9 No NA NA Yes Foc 10 No NA NA Nc NA 11 Yes Mld Foc Yes Mult 12 No NA NA Yes Foc 13 No NA NA Yes Mult 14 No NA NA Yes Foc 15 Yes Mld Mult Yes Foc 16 No NA NA Yes Mult 17 Yes Mld Foc Yes Foc 18 Yes Mld Mult Nc NA 19 No NA NA Yes Foc 20 Yes Mld Foc Yes Foc 21 Yes Mld Foc Yes Foc 22 No NA NA Yes Mult 23 Yes Mld Foc Yes Foc 24 Yes Mld Foc Yes Foc 25 No NA NA Yes Mult 26 No NA NA Yes Foc 27 Yes Mld Foc Yes Mult 28 No NA NA Yes Foc 29 No NA NA Yes Mult 30 No NA NA Yes Mult Abbreviations: Cell, cellular; Chr, chronic; Confl, confluent; Diff, diffuse; Foc, focal; Foll, follicular; Gd, good; Inter, interstitial; Marg, marginal; Mld, mild; Mod, moderate; Mult, multifocal; NA, not applicable; No, none; Sev, severe; UIP, usual interstitial pneumonia; NC, no concensus. a 7 5 Chronic fibrosing interstitial pneumonia, unclassifed; 8 5 Chronic fibrosing interstitial pneumonia with honeycomb, unclassified; 9 5 Acute and chronic interstitial pneumonia, unclassified; 10 5 Honeycombing only. b 15 Eosinophilic; 2 5 Siderotic; 3 5 Vacuolated; 4 5 Mixed. c Focal to confluent. Numbers are an average of 3 reviewers9 input. d No. thickened in 10 vessels. Numbers are an average of 3 reviewers9 input. Table 4. Consensus on Major Observations in Familial Idiopathic Interstitial Pneumonia (n = 30) Observation No. of Cases (%) Smooth muscle hyperplasia in fibrosis 28 (93) Microscopic honeycombing 27 (90) Fibroblast foci 26 (87) Peripheral lobular fibrosis 18 (60) Chronic bronchiolitis 18 (60) Diffuse septal fibrosis (multifocal) 12 (40) Vascular adventitial fibrosis.2 12 (40) Squamous metaplasia 12 (40) Peribronchiolar fibrosis, multifocal 11 (37) Diffuse chronic inflammation 10 (33) Focal air space organization 10 (33) Intra-alveolar eosinophils 9 (27) Consensus UIP DX 12 (40) Abbreviation, UIP DX, Usual interstitial pneumonia diagnosis. Table 5. k Coefficient (Interobserver Agreement) With 95% Confidence Interval and P Value a Reader Comparison k LCB UCB P Value UIP versus not UIP Path 1: Path Path 1: Path Path 2: Path FF (+/2) Path 1: Path ,.001 Path 1: Path ,.001 Path 2: Path ,.001 MHC (+/2) Path 1: Path Path 1: Path Path 2: Path SPF (+/2) Path 1: Path Path 1: Path Path 2: Path DSF (+/2) Path 1: Path Path 1: Path Path 2: Path DCI (+/2) Path 1: Path Path 1: Path Path 2: Path SMH (+/2) Path 1: Path Path 1: Path Path 2: Path Abbreviations: DCI, diffuse chronic inflammation; DSF, diffuse alveolar septal fibrosis; FF, fibroblast foci; LCB, lower confidence bound; MHC, microscopic honeycomb remodeling; Path, pathologist; SMH, smooth muscle hyperplasia in fibrosis; SPF, subpleural peripheral accentuation of fibrosis; UCB, upper confidence bound; UIP, usual interstitial pneumonia. a Assessments for each feature were first converted to UIP-not UIP and present-absent. For the present-absent assessment, a feature with a zero value was considered to be absent while any degree identified (1 3) was considered as a feature that was present. of death in 12 subjects. The atypical histopathologic features arguing against a diagnosis of UIP did seem to have a survival influence however, as those patients with F-IIP who achieved a consensus histopathologic pattern of UIP had a significantly earlier age at death by 10 years. The veracity of this finding will require confirmation in a larger cohort of patients with F-IIP. CONCLUSIONS The pathologic process underlying F-IIP was most frequently one of advanced and unclassifiable interstitial fibrosis with a high incidence of histopathologic honeycombing, smooth muscle hyperplasia in fibrosis, and fibroblast foci, in varying combinations. The biopsy specimens frequently lacked temporal heterogeneity, a critical and distinctive attribute of UIP. MoreoverÐ, even when 1 or 2 features were suggestive of UIP, non-uip features were often present, such as diffuse chronic inflammation, diffuse alveolar septal fibrosis, alveolar space eosinophils, squamous metaplasia, and/or multifocal peribronchiolar fibrosis. The extent of histopathologic fibrosis Arch Pathol Lab Med Vol 136, November 2012 Pathology of Familial Idiopathic Interstitial Pneumonia Leslie et al 1375
11 may explain why historical studies of familial IIP concluded that the pathology was UIP at a time when the criteria for this diagnosis were less strictly applied. In our study, UIP by current criteria was identified by consensus in only 40% of cases, and this subset of patients had a significantly earlier age at death than the remainder of the study population, arguing for a more aggressive phenotype. The authors are grateful to the patients and families who participated in this study. We thank Ms Janet Talbert of National Jewish Health for assistance in data entry and Henry Tazelaar, MD, for critical review of the final manuscript. References 1. Leslie KO, Colby TV. Classification and pathology of diffuse interstitial lung disease. Semin Clin Immunol. 1999;1: Leslie KO. Pathology of interstitial lung disease. Clin Chest Med. 2004; 25(4): , vi. 3. Leslie KO. Pathology of the idiopathic interstitial pneumonias. Exp Lung Res. 2005;31(suppl 1): Travis W, King TJ, Bateman E, et al. American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2002;165(2): Rybicki BA, Iannuzzi MC, Frederick MM, et al. Familial aggregation of sarcoidosis: a case-control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med. 2001;164(11): Jablonska S. Familial occurrence of scleroderma. J Eur Acad Dermatol Venereol. 2001;15(1): Taneja V, Mehra NK, Singh RR, Anand C, Malaviya AN. Immunogenetics of familial rheumatoid arthritis: a study of 41 multicase families. J Rheumatol. 1993; 20(2): Alarcon-Segovia D, Alarcon-Riquelme ME, Cardiel MH, et al. Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort. Arthritis Rheum. 2005;52(4): Lichtenfeld JL, Kirschner RH, Wiernik PH. Familial Sjogren s syndrome with associated primary salivary gland lymphoma. Am J Med. 1976;60(2): Carsillo T, Astrinidis A, Henske EP. Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis. Proc Natl Acad Sci U S A. 2000;97(11): Krisp A, Hoffman R, Happle R, Konig A, Freyschmidt-Paul P. Hermansky- Pudlak syndrome. Eur J Dermatol. 2001;11(4): Riccardi VM. Von Recklinghausen neurofibromatosis. N Engl J Med. 1981; 305(27): Auwerx J, Demedts M, Bouillon R, Desmet J. Coexistence of hypocalciuric hypercalcaemia and interstitial lung disease in a family: a cross-sectional study. Eur J Clin Invest. 1985;15(1): Lee HL, Ryu JH, Wittmer MH, et al. Familial idiopathic pulmonary fibrosis: clinical features and outcome. Chest. 2005;127(6): Marshall RP, Puddicombe A, Cookson WO, Laurent GJ. Adult familial cryptogenic fibrosing alveolitis in the United Kingdom. Thorax. 2000;55(2): Wahidi MM, Speer MC, Steele MP, et al. Familial pulmonary fibrosis in the United States. Chest. 2002;121(suppl 3):30S. 17. Hodgson U, Laitinen T, Tukiainen P. Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland. Thorax. 2002;57(4): Peabody JW, Peabody JW Jr, Hayes EW, Hayes EW Jr. Idiopathic pulmonary fibrosis; its occurrence in identical twin sisters. Dis Chest. 1950; 18(4): Steele MP, Speer MC, Loyd JE, et al. Clinical and pathologic features of familial interstitial pneumonia. Am J Respir Crit Care Med. 2005;172(9): Nishiyama O, Taniguchi H, Kondoh Y, et al. Familial idiopathic pulmonary fibrosis: serial high-resolution computed tomography findings in 9 patients. J Comput Assist Tomogr. 2004;28(4): Altman D. Practical Statistics for Medical Research. London, UK: Chapman & Hall; 1991: Inter-rater agreement, Katzenstein AL, Fiorelli RF. Nonspecific interstitial pneumonia/fibrosis: histologic features and clinical significance. Am J Surg Pathol. 1994;18(2): Katzenstein AL, Myers JL. Nonspecific interstitial pneumonia and the other idiopathic interstitial pneumonias: classification and diagnostic criteria. Am J Surg Pathol. 2000; 24(1): Verleden GM, du Bois RM, Bouros D, et al. Genetic predisposition and pathogenetic mechanisms of interstitial lung diseases of unknown origin. Eur Respir J Suppl. 2001;32:17s 29s. 25. Sandoz E. Uber zwei falle von fotaler bronchektsie [in German]. Beitr Pathol Anat. 1907;41: MacMillan JM. Familial pulmonary fibrosis. Dis Chest. 1951;20(4): Manigand G, Oury M, Faux N, Lemaigre G, Thomas I. Familial diffuse interstitial pulmonary fibrosis [in French]. Nouv Presse Med. 1982;11(1): McDonnell L, Sweeney EC, Jagoe WS, FitzGerald MX. Familial pulmonary fibrosis and lung cancer. Ir J Med Sci. 1982;151(10): Murphy A, O Sullivan BJ. Familial fibrosing alveolitis. Ir J Med Sci. 1981; 150(7): Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6): Flaherty KR, Travis WD, Colby TV, et al. Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med. 2001; 164(9): Nicholson AG, Addis BJ, Bharucha H, et al. Inter-observer variation between pathologists in diffuse parenchymal lung disease. Thorax. 2004;59(6): Arch Pathol Lab Med Vol 136, November 2012 Pathology of Familial Idiopathic Interstitial Pneumonia Leslie et al
NONE OVERVIEW FINANCIAL DISCLOSURES UPDATE ON IDIOPATHIC PULMONARY FIBROSIS/IPF (UIP) FOR PATHOLOGISTS. IPF = Idiopathic UIP Radiologic UIP Path UIP
UPDATE ON IDIOPATHIC PULMONARY FIBROSIS/IPF () FOR PATHOLOGISTS Thomas V. Colby, M.D. Professor of Pathology (Emeritus) Mayo Clinic Arizona FINANCIAL DISCLOSURES NONE OVERVIEW IPF Radiologic Dx Pathologic
More informationUsual Interstitial pneumonia and Nonspecific Interstitial Pneumonia. Nitra and the Gangs.
Usual Interstitial pneumonia and Nonspecific Interstitial Pneumonia Nitra and the Gangs. บทน ำและบทท ๓, ๑๐, ๑๒, ๑๓, ๑๔, ๑๕, ๑๗ Usual Interstitial Pneumonia (UIP) Most common & basic pathologic pattern
More informationDisclosures. Fibrotic lung diseases: Basic Principles, Common Problems, and Reporting. Relevant financial relationships: None. Off-label usage: None
Fibrotic lung diseases: Basic Principles, Common Problems, and Reporting Brandon T. Larsen, MD, PhD Senior Associate Consultant Department of Laboratory Medicine and Pathology Mayo Clinic Arizona Arizona
More informationCTD-related Lung Disease
13 th Cambridge Chest Meeting King s College, Cambridge April 2015 Imaging of CTD-related Lung Disease Dr Sujal R Desai King s College Hospital, London Disclosure Statement No Disclosures / Conflicts of
More information11/10/2014. Multi-disciplinary Approach to Diffuse Lung Disease: The Imager s Perspective. Radiology
Multi-disciplinary Approach to Diffuse Lung Disease: The Imager s Perspective Radiology Pathology Clinical 1 Role of HRCT Diagnosis Fibrosis vs. inflammation Next step in management Response to treatment
More information5/9/2015. Multi-disciplinary Approach to Diffuse Lung Disease: The Imager s Perspective. No, I am not a pulmonologist! Radiology
Multi-disciplinary Approach to Diffuse Lung Disease: The Imager s Perspective No, I am not a pulmonologist! Radiology Pathology Clinical 1 Everyone needs a CT Confidence in diagnosis Definitive HRCT +
More informationCase 4 History. 58 yo man presented with prox IP joint swelling 2 months later pain and swelling in multiple joints Chest radiograph: bi-basilar
Case 4 History 58 yo man presented with prox IP joint swelling 2 months later pain and swelling in multiple joints Chest radiograph: bi-basilar basilar infiltrates suggestive of pulmonary fibrosis Open
More informationDifferential diagnosis
Differential diagnosis Idiopathic pulmonary fibrosis (IPF) is part of a large family of idiopathic interstitial pneumonias (IIP), one of four subgroups of interstitial lung disease (ILD). Differential
More informationDiffuse Interstitial Lung Diseases: Is There Really Anything New?
: Is There Really Anything New? Sujal R. Desai, MBBS, MD ESTI SPEAKER SUNDAY Society of Thoracic Radiology San Antonio, Texas March 2014 Diffuse Interstitial Lung Disease The State of Play DILDs Is There
More informationCOI: no conflicts of interest to declare
Idiopathic versus secondary Usual Interstitial Pneumonia (UIP) pattern in a series of 96 consecutive surgical lung biopsies: The value of histologic ancillary findings in a multidisciplinary discussion
More informationHistopathologic Approach to Interstitial Lung Disease
Histopathologic Approach to Interstitial Lung Disease Kirk D. Jones, MD UCSF Dept of Pathology kirk.jones@ucsf.edu Disclosures I have nothing to disclose 1 Why? Much of interstitial lung disease biopsies
More information4/17/2010 C ini n ca c l a Ev E a v l a ua u t a ion o n of o ILD U dat a e t e i n I LDs
Update in ILDs Diagnosis 101: Clinical Evaluation April 17, 2010 Jay H. Ryu, MD Mayo Clinic, Rochester MN Clinical Evaluation of ILD Outline General aspects of ILDs Classification of ILDs Clinical evaluation
More informationProgress in Idiopathic Pulmonary Fibrosis
Progress in Idiopathic Pulmonary Fibrosis David A. Lynch, MB Disclosures Progress in Idiopathic Pulmonary Fibrosis David A Lynch, MB Consultant: t Research support: Perceptive Imaging Boehringer Ingelheim
More informationDiffuse interstitial lung diseases (DILDs) are a heterogeneous group of non-neoplastic, noninfectious
Focused Issue of This Month Diagnostic Approaches to Diffuse Interstitial Lung Diseases Dong Soon Kim, MD Department of Pulmonary and Critical Care Medicine, University of Ulsan College of Medicine E -
More informationNon-neoplastic Lung Disease II
Pathobasic Non-neoplastic Lung Disease II Spasenija Savic Prince Pathology Program Systematic approach to surgical lung biopsies with ILD Examples (chronic ILD): Idiopathic interstitial pneumonias: UIP,
More informationI don t need you. Disclosure Statement. Pathology Approach to ILD 11/5/2016. Kirk D. Jones, MD UCSF Dept of Pathology
Pathology Approach to ILD Disclosure Statement Relevant financial relationships with a commercial interest: Boeringer Ingleheim, speaker Kirk D. Jones, MD UCSF Dept of Pathology kirk.jones@ucsf.edu I don
More informationDIFFERENCES IN FIBROPROLIFERATIVE HEALING IN EXOGENEOUS AND IDIOPATHIC ILDs. ARE THERE ANY?
NIHR Southampton Respiratory Biomedical Research Unit DIFFERENCES IN FIBROPROLIFERATIVE HEALING IN EXOGENEOUS AND IDIOPATHIC ILDs. ARE THERE ANY? Fibrosing Interstitial Lung Diseases CPFS/WASOG/AIPO/ERS
More informationCase Presentations in ILD. Harold R. Collard, MD Department of Medicine University of California San Francisco
Case Presentations in ILD Harold R. Collard, MD Department of Medicine University of California San Francisco Outline Overview of diagnosis in ILD Definition/Classification High-resolution CT scan Multidisciplinary
More informationChallenges in the Diagnosis of Interstitial Lung Disease
Challenges in the Diagnosis of Interstitial Lung Disease Kirk D. Jones, MD UCSF Dept. of Pathology kirk.jones@ucsf.edu Overview New Classification of IIP Prior classification Modifications for new classification
More informationHRCT in Diffuse Interstitial Lung Disease Steps in High Resolution CT Diagnosis. Where are the lymphatics? Anatomic distribution
Steps in High Resolution CT Diagnosis Pattern of abnormality Distribution of disease Associated findings Clinical history Tomás Franquet MD What is the diagnosis? Hospital de Sant Pau. Barcelona Secondary
More informationChallenges in the Diagnosis of Interstitial Lung Disease
Challenges in the Diagnosis of Interstitial Lung Disease Kirk D. Jones, MD UCSF Dept. of Pathology kirk.jones@ucsf.edu Overview New Classification of IIP Prior classification Modifications for new classification
More informationDiagnosing Idiopathic Pulmonary Fibrosis on Evidence-Based Guidelines
Diagnosing Idiopathic Pulmonary Fibrosis on Evidence-Based Guidelines Rebecca Keith, MD Assistant Professor, Division of Pulmonary and Critical Care Medicine National Jewish Health, Denver, CO Objectives
More informationCombined Unclassifiable Interstitial Pneumonia and Emphysema: A Report of Two Cases
CASE REPORT Combined Unclassifiable Interstitial Pneumonia and Emphysema: A Report of Two Cases Nobuhiko Nagata 1, Kentaro Watanabe 2, Michihiro Yoshimi 3, Hiroshi Okabayashi 4, Katsuo Sueishi 5, Kentaro
More informationUnpaid scientific collaborator & advisor with Veracyte, Inc.
Diagnosis and Classification of Idiopathic Interstitial Pneumonias: Role of Histopathology in the Golden Age of Consensus Jeffrey L. Myers, M.D. A. James French Professor of Diagnostic Pathology Vice Chair
More informationFinancial disclosure COMMON DIAGNOSES IN HRCT. High Res Chest HRCT. HRCT Pre test. I have no financial relationships to disclose. Anatomy Nomenclature
Financial disclosure I have no financial relationships to disclose. Douglas Johnson D.O. Cardiothoracic Imaging Gaston Radiology COMMON DIAGNOSES IN HRCT High Res Chest Anatomy Nomenclature HRCT Sampling
More informationPathologic Assessment of Interstitial Lung Disease
Pathologic Assessment of Interstitial Lung Disease Dry and itchy? It could be eczema or fungal infection. We don t need to worry, the drugs aren t that dangerous. Kirk D. Jones, MD UCSF Dept. of Pathology
More informationReplacement of air with fluid, inflammatory. cells or cellular debris. Parenchymal, Interstitial (Restrictive) and Vascular Diseases.
Parenchymal, Interstitial (Restrictive) and Vascular Diseases Alain C. Borczuk, M.D. Dept of Pathology Replacement of air with fluid, inflammatory cells Pulmonary Edema Pneumonia Hemorrhage Diffuse alveolar
More informationImaging: how to recognise idiopathic pulmonary fibrosis
REVIEW IDIOPATHIC PULMONARY FIBROSIS Imaging: how to recognise idiopathic pulmonary fibrosis Anand Devaraj Affiliations: Dept of Radiology, St George s Hospital, London, UK. Correspondence: Anand Devaraj,
More informationOutline Definition of Terms: Lexicon. Traction Bronchiectasis
HRCT OF IDIOPATHIC INTERSTITIAL PNEUMONIAS Disclosures Genentech, Inc. Speakers Bureau Tadashi Allen, MD University of Minnesota Assistant Professor Diagnostic Radiology 10/29/2016 Outline Definition of
More informationA Review of Interstitial Lung Diseases
Outline A Review of Interstitial Lung Diseases Paul J. Wolters, MD Associate Professor Department of Medicine University of California San Francisco Overview of diagnosis in ILD Why it is important Definition/Classification
More informationA Review of Interstitial Lung Diseases. Paul J. Wolters, MD Associate Professor Department of Medicine University of California San Francisco
A Review of Interstitial Lung Diseases Paul J. Wolters, MD Associate Professor Department of Medicine University of California San Francisco Outline Overview of diagnosis in ILD Why it is important Definition/Classification
More informationParenchymal, Interstitial i (Restrictive) i and Vascular Diseases
Pulmonary Diseases: Structure-Function Correlation II Parenchymal, Interstitial i (Restrictive) i and Vascular Diseases Alain C. Borczuk, M.D. Dept of Pathology Pulmonary Diseases: Structure-Function Correlation
More informationEpidemiology and classification of smoking related interstitial lung diseases
Epidemiology and classification of smoking related interstitial lung diseases Šterclová M. Department of Respiratory Diseases, Thomayer Hospital, Prague, Czech Republic Supported by an IGA Grant No G 1207
More informationLiebow and Carrington's original classification of IIP
Liebow and Carrington's original classification of IIP-- 1969 Eric J. Stern MD University of Washington UIP Usual interstitial pneumonia DIP Desquamative interstitial pneumonia BIP Bronchiolitis obliterans
More informationPulmonary manifestations of CTDs Diagnosis, differential diagnosis and treatment
Prague, June 2014 Pulmonary manifestations of CTDs Diagnosis, differential diagnosis and treatment Katerina M. Antoniou, MD, PhD As. Professor in Thoracic Medicine ERS ILD Group Secretary Medical School,
More informationRestrictive lung diseases
Restrictive lung diseases Restrictive lung diseases are diseases that affect the interstitium of the lung. Interstitium of the lung is the very thin walls surrounding the alveoli, it s formed of epithelium
More informationI n 2002 the American Thoracic Society (ATS) and
1008 REVIEW SERIES Challenges in pulmonary fibrosis? 5: The NSIP/UIP debate Roland du Bois, Talmadge E King Jr... Among the idiopathic interstitial s, the two entities idiopathic pulmonary fibrosis (IPF)
More informationManish Powari Regional Training Day 10/12/2014
Manish Powari Regional Training Day 10/12/2014 Large number of different types of Interstitial Lung Disease (ILD). Most are very rare Most patients present with one of a smaller number of commoner diseases
More informationKey words: CT scanners; interstitial lung diseases; polymyositis-dermatomyositis; x-ray
Nonspecific Interstitial Pneumonia Associated With Polymyositis and Dermatomyositis* Serial High-Resolution CT Findings and Functional Correlation Hiroaki Arakawa, MD; Hidehiro Yamada, MD; Yasuyuki Kurihara,
More informationPrognostic Significance of Histopathologic Subsets in Idiopathic Pulmonary Fibrosis
Prognostic Significance of Histopathologic Subsets in Idiopathic Pulmonary Fibrosis JULIE A. BJORAKER, JAY H. RYU, MARK K. EDWIN, JEFFREY L. MYERS, HENRY D. TAZELAAR, DARRELL R. SCHROEDER, and KENNETH
More informationDiagnostic Approach to Advanced Fibrotic Interstitial Lung Disease. Bringing Together Clinical, Radiologic, and Histologic Clues
Diagnostic Approach to Advanced Fibrotic Interstitial Lung Disease Bringing Together Clinical, Radiologic, and Histologic Clues Brandon T. Larsen, MD, PhD; Maxwell L. Smith, MD; Brett M. Elicker, MD; Jessica
More informationIPF: Epidemiologia e stato dell arte
IPF: Epidemiologia e stato dell arte Clinical Classification Diffuse parenchimal lung diseases Exposure-related: - occupational - environmental - medication Desquamative interstitial pneumonia Idiopathic
More informationOverview of Idiopathic Pulmonary Fibrosis: Diagnosis and Therapy
Overview of Idiopathic Pulmonary Fibrosis: Diagnosis and Therapy Jeff Swigris, DO, MS Director, ILD Program National Jewish Health Disclosures Speaker - Boehringer Ingelheim and Genentech Objectives Describe
More informationRadiologic pathologic discordance in biopsy-proven usual interstitial pneumonia
ERJ Express. Published on February 25, 2016 as doi: 10.1183/13993003.01680-2015 ORIGINAL ARTICLE IN PRESS CORRECTED PROOF Radiologic pathologic discordance in biopsy-proven usual interstitial pneumonia
More informationIPF AND OTHER FIBROSING LUNG DISEASE: WHAT DRUGS MIGHT WORK AND ON WHOM DO THEY W ORK?
IPF AND OTHER FIBROSING LUNG DISEASE: WHAT DRUGS MIGHT WORK AND ON WHOM DO THEY W ORK? KEVIN K. BROWN, MD PROFESSOR AND VICE CHAIRMAN, DEPARTMENT OF MEDICINE NATIONAL JEWISH HEALTH DENVER, CO Kevin K.
More informationNonspecific interstitial pneumonia and usual interstitial pneumonia: comparison of the clinicopathologic features and prognosis
Original Article Nonspecific interstitial pneumonia and usual interstitial pneumonia: comparison of the clinicopathologic features and prognosis Xia Li 1, Chang Chen 2, Jinfu Xu 1, Jinming Liu 1, Xianghua
More informationBeyond a consensus classification for idiopathic interstitial pneumonias: progress and controversies
Histopathology 2009, 54, 90 103. DOI: 10.1111/j.1365-2559.2008.03173.x REVIEW Beyond a consensus classification for idiopathic interstitial pneumonias: progress and controversies Jeffrey L Myers & Anna-Luise
More informationTBLB is not recommended as the initial biopsy option in cases of suspected IPF and is unreliable in the diagnosis of rare lung disease (other than
TBLB is not recommended as the initial biopsy option in cases of suspected IPF and is unreliable in the diagnosis of rare lung disease (other than PAP) BAL is not required as a diagnostic tool in patients
More informationInternational consensus statement on idiopathic pulmonary fibrosis
Eur Respir J 2001; 17: 163 167 Printed in UK all rights reserved Copyright #ERS Journals Ltd 2001 European Respiratory Journal ISSN 0903-1936 PERSPECTIVE International consensus statement on idiopathic
More informationDisclosures. Traditional Paradigm. Overview 4/17/2010. I have relationships with the following organizations and companies:
Disclosures Pharmacological Therapy for ILD What to Use and How to Use It Harold R Collard MD Interstitial Lung Disease Program University of California San Francisco (UCSF) I have relationships with the
More informationOFEV MEDIA BACKGROUNDER
OFEV MEDIA BACKGROUNDER 1 What is OFEV (nintedanib*)? 2 How does OFEV (nintedanib*) work? 3 Data overview 4 OFEV (nintedanib*) approval status 1 What is OFEV (nintedanib*)? OFEV (nintedanib*) is a small
More informationCLEARING THE AIR ON DIFFUSE PARENCHYMAL (INTERSTITIAL) LUNG DISEASE (ILD)
CLEARING THE AIR ON DIFFUSE PARENCHYMAL (INTERSTITIAL) LUNG DISEASE (ILD) David Northrop MBA, RRT Assistant Director of Respiratory Therapy Services The University of Kansas Health System Clinical Assistant
More informationARTICLE IN PRESS. Ahuva Grubstein a, Daniele Bendayan b, Ithak Schactman c, Maya Cohen a, David Shitrit b, Mordechai R. Kramer b,
Respiratory Medicine (2005) 99, 948 954 Concomitant upper-lobe bullous emphysema, lower-lobe interstitial fibrosis and pulmonary hypertension in heavy smokers: report of eight cases and review of the literature
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Idiopathic Pulmonary Fibrosis Page 1 of 10 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Idiopathic Pulmonary Fibrosis (Esbriet /pirfenidone, Ofev /nintedanib)
More informationTerminal Diffuse Alveolar Damage in Relation to Interstitial Pneumonias An Autopsy Study
Anatomic Pathology / DIFFUSE ALVEOLAR DAMAGE AS A TERMINAL EVENT Terminal Diffuse Alveolar Damage in Relation to Interstitial Pneumonias An Autopsy Study Alexandra J. Rice, MBBChir, 1 Athol U. Wells, MD,
More informationDiagnostic challenges in IPF
Medicine, Nursing and Health Sciences Diagnostic challenges in IPF Dr Ian Glaspole Central and Eastern Clinical School, Alfred Hospital and Monash University March 2015 Disclosures Consultancy fees from
More informationThe Egyptian Journal of Hospital Medicine (July 2017) Vol.68 (2), Page
The Egyptian Journal of Hospital Medicine (July 2017) Vol.68 (2), Page 1135-1140 Role of High Resolution Computed Tomography in Diagnosis of Interstitial Lung Diseases in Patients with Collagen Diseases
More informationThe radiological differential diagnosis of the UIP pattern
5th International Conference on Idiopathic Pulmonary Fibrosis, Modena, 2015, June 12th The radiological differential diagnosis of the UIP pattern Simon Walsh King s College Hospital Foundation Trust London,
More informationUpdate on Pulmonary Fibrosis
Update on Pulmonary Fibrosis Not All Fibrosis Is Created Equally Maxwell L. Smith, MD Context. Three distinct patterns of pulmonary fibrosis, including usual interstitial pneumonia, fibrotic nonspecific
More informationAcute and Chronic Lung Disease
KATHOLIEKE UNIVERSITEIT LEUVEN Faculty of Medicine Acute and Chronic Lung Disease W De Wever, JA Verschakelen Department of Radiology, University Hospitals Leuven, Belgium Clinical utility of HRCT To detect
More informationCareful histopathological evaluation has shown the traditionally clinical diagnosis of
Demystifying Idiopathic Interstitial Pneumonia Harold R. Collard, MD; Talmadge E. King, Jr, MD REVIEW ARTICLE Careful histopathological evaluation has shown the traditionally clinical diagnosis of idiopathic
More informationINVITED REVIEW SERIES: PULMONARY FIBROSIS SERIES EDITORS: MARTIN KOLB AND GERARD COX
INVITED REVIEW SERIES: PULMONARY FIBROSIS SERIES EDITORS: MARTIN KOLB AND GERARD COX Diagnosing fibrotic lung disease: When is high-resolution computed tomography sufficient to make a diagnosis of idiopathic
More informationCriteria for confident HRCT diagnosis of usual interstitial pneumonia (UIP)
Criteria for confident HRCT diagnosis of usual interstitial pneumonia (UIP) Assem El Essawy (1) & Amr A. Nassef (٢) Abstract Identification of interstitial pneumonia (IP) was mainly based on histological
More informationIPF - Inquadramento clinico
IPF - Inquadramento clinico Sergio Harari Unità Operativa di Pneumologia UTIR Servizio di Fisiopat. Resp. e Emodinamica Polmonare Ospedale S. Giuseppe, Milano Clinical Classification Diffuse parenchimal
More informationINTERSTITIAL LUNG DISEASE. Radhika Reddy MD Pulmonary/Critical Care Long Beach VA Medical Center January 5, 2018
INTERSTITIAL LUNG DISEASE Radhika Reddy MD Pulmonary/Critical Care Long Beach VA Medical Center January 5, 2018 Interstitial Lung Disease Interstitial Lung Disease Prevalence by Diagnosis: Idiopathic Interstitial
More informationHypersensitivity Pneumonitis Common Diagnostic and Treatment Dilemmas
Hypersensitivity Pneumonitis Common Diagnostic and Treatment Dilemmas Rishi Raj MD Director, Interstitial Lung Diseases Program Clinical Professor of Pulmonary and Critical Care Medicine Stanford University
More informationBronchoalveolar Lavage and Histopathologic Diagnosis Based on Biopsy
Idiopathic Pulmonary Fibrosis Bronchoalveolar Lavage and Histopathologic Diagnosis Based on Biopsy JMAJ 46(11): 469 474, 2003 Yukihiko SUGIYAMA Professor, Division of Pulmonary Medicine, Department of
More informationHYPERSENSITIVITY PNEUMONITIS
HYPERSENSITIVITY PNEUMONITIS A preventable fibrosis MOSAVIR ANSARIE MB., FCCP INTERSTITIAL LUNG DISEASES A heterogeneous group of non infectious, non malignant diffuse parenchymal disorders of the lower
More informationCT Scan Findings of Probable Usual Interstitial Pneumonitis Have a High Predictive Value for Histologic Usual Interstitial Pneumonitis
[ Original Research Diffuse Lung Disease ] CT Scan Findings of Probable Usual Interstitial Pneumonitis Have a High Predictive Value for Histologic Usual Interstitial Pneumonitis Jonathan H. Chung, MD ;
More informationConnective Tissue Disorder- Associated Interstitial Lung Disease (CTD-ILD) and Updates
Connective Tissue Disorder- Associated Interstitial Lung Disease (CTD-ILD) and Updates Maria Elena Vega, M.D Assistant Professor of Medicine Lewis Katz School of Medicine at Temple University Nothing to
More informationThoracic lung involvement in rheumatoid arthritis: Findings on HRCT
Thoracic lung involvement in rheumatoid arthritis: Findings on HRCT Poster No.: C-2488 Congress: ECR 2015 Type: Educational Exhibit Authors: R. E. Correa Soto, M. J. Martín Sánchez, J. M. Fernandez 1 1
More informationJune 2013 Pulmonary Case of the Month: Diagnosis Makes a Difference. Lewis J. Wesselius, MD 1 Henry D. Tazelaar, MD 2
June 2013 Pulmonary Case of the Month: Diagnosis Makes a Difference Lewis J. Wesselius, MD 1 Henry D. Tazelaar, MD 2 Departments of Pulmonary Medicine 1 and Laboratory Medicine and Pathology 2 Mayo Clinic
More information* * APPROACH TO NON- NEOPLASTIC LUNG DISEASE IN TRANSBRONCHIAL AND SURGICAL BIOPSIES. Financial Disclosures: NONE. BIOPSY TECHNIQUES Bronchoscopic
APPROACH TO NON- NEOPLASTIC LUNG DISEASE IN TRANSBRONCHIAL AND SURGICAL BIOPSIES Thomas V. Colby, M.D. Mayo Clinic Arizona Geraldine C. Zeiler Professor of Cytopathology Mayo Clinic Arizona Financial Disclosures:
More informationIn medicine, the term overlap is very common, to the extent that there is even a
Case Report Payam Mehrian (MD) 1 Ali Cheraghvandi (MD) 2 Atousa Droudnia (PhD) 3 Firouzeh Talischi (MD) 4 Saeid Fallah Tafti (MD) *5 Shahram Kahkouee (MD) 6 Hamidreza Jamaati (MD) 7 1. Pediatric Respiratory
More informationSmoking-related lung pathology represents a histologically
A Review of Smoking-Related Interstitial Fibrosis, Respiratory Bronchiolitis, and Desquamative Interstitial Pneumonia Overlapping Histology and Confusing Terminology Smoking-related lung diseases traverse
More informationUNRAVELING THE ETIOLOGY OF FAMILIAL INTERSTITIAL PNEUMONIA: GENETIC INVESTIGATIONS OF A COMPLEX DISEASE. Anastasia Leigh Wise
UNRAVELING THE ETIOLOGY OF FAMILIAL INTERSTITIAL PNEUMONIA: GENETIC INVESTIGATIONS OF A COMPLEX DISEASE by Anastasia Leigh Wise University Program in Genetics and Genomics & Integrated Toxicology and Environmental
More informationDiagnosing ILD. What is important in 2016? Chris Grainge
Diagnosing ILD What is important in 2016? Chris Grainge Senior Staff Specialist Respiratory Medicine John Hunter Hospital Conjoint A/Prof University of Newcastle Conflict of interest I have acted as a
More informationCurrent diagnostic recommendations for ILD: The multidisciplinary meeting TSANZSRS ASM
Medicine, Nursing and Health Sciences Current diagnostic recommendations for ILD: The multidisciplinary meeting Dr Ian Glaspole Central and Eastern Clinical School, Alfred Hospital and Monash University
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Hunninghake GM, Hatabu H, Okajima Y, et al. MUC5B promoter
More informationBronkhorst colloquium Interstitiële longziekten. Katrien Grünberg, klinisch patholoog
Bronkhorst colloquium 2013-2014 Interstitiële longziekten De pathologie achter de CT Katrien Grünberg, klinisch patholoog K.grunberg@vumc.nl Preparing: introduction and 3 cases The introduction on microscopic
More informationIdiopathic Nonspecific Interstitial Pneumonia Report of an American Thoracic Society Project
Idiopathic Nonspecific Interstitial Pneumonia Report of an American Thoracic Society Project William D. Travis 1 *, Gary Hunninghake 2 *, Talmadge E. King, Jr. 3 *, David A. Lynch 4 *, Thomas V. Colby
More informationINTERSTITIAL LUNG DISEASES: FOCUS ON IDIOPATHIC PULMONARY FIBROSIS (IPF)
INTERSTITIAL LUNG DISEASES: FOCUS ON IDIOPATHIC PULMONARY FIBROSIS (IPF) Marilyn K. Glassberg Csete, M.D. Professor of Medicine, Surgery, and Pediatrics Director, Interstitial and Rare Lung Disease Program
More informationIdiopathic interstitial pneumonias (IIPs) are a group of
SYMPOSIA C. Isabela S. Silva, MD, PhD and Nestor L. Müller, MD, PhD Abstract: The idiopathic interstitial pneumonias (IIPs) are a group of diffuse parenchymal lung diseases of unknown etiology characterized
More informationIdiopathic Pulmonary Fibrosis: The Importance of Qualitative and Quantitative Phenotyping
Idiopathic Pulmonary Fibrosis: The Importance of Qualitative and Quantitative Phenotyping K. R. Flaherty Division of Pulmonary and Critical Care Medicine, University of Michigan Health System, Ann Arbor,
More informationThe Spectrum of Management of Pulmonary Ground Glass Nodules
The Spectrum of Management of Pulmonary Ground Glass Nodules Stanley S Siegelman CT Society 10/26/2011 No financial disclosures. Noguchi M et al. Cancer 75: 2844-2852, 1995. 236 surgically resected peripheral
More informationI diopathic pulmonary fibrosis (IPF) is the most common
1091 INTERSTITIAL LUNG DISEASE Relationship between histopathological features and the course of idiopathic pulmonary fibrosis/usual interstitial pneumonia L Tiitto, R Bloigu, U Heiskanen, P Pääkkö, V
More informationIdiopathic Pulmonary of Care
Chapter 6.1 Living Medical etextbook A Digital Tool at the Point of Care From Projects In Knowledge Pulmonology Idiopathic Pulmonary Fibrosis @Point of Care IPF Case Study: Typical Presentation, Role of
More informationHypersensitivity Pneumonitis: Spectrum of High-Resolution CT and Pathologic Findings
CT of Hypersensitivity Pneumonitis Chest Imaging Pictorial Essay C. Isabela S. Silva 1 ndrew Churg 2 Nestor L. Müller 1 Silva CIS, Churg, Müller NL Keywords: high-resolution CT, hypersensitivity pneumonitis,
More informationH ypersensitivity pneumonitis (HP) comprises a group of
665 INTERSTITIAL LUNG DISEASE Chronic bird fancier s lung: histopathological and clinical correlation. An application of the 2002 ATS/ERS consensus classification of the idiopathic interstitial pneumonias
More informationDefinition, classification and epidemiology
Interstitial Lung Diseases Definition, classification and epidemiology Haluk Türktaş Professor of Pulmonary Medicine Gazi University Ankara Interstitial Lung Diseases Definition of ILD A diverse group
More informationDifficulties Diagnosing Idiopathic Pulmonary Fibrosis
1. er Encuentro Entre Neumólogos y Radiólogos, Madrid, Spain, 2016, October 14th Difficulties Diagnosing Idiopathic Pulmonary Fibrosis Simon Walsh King s College Hospital Foundation Trust London, United
More informationRadiologic Approach to Smoking Related Interstitial Lung Disease
Radiologic Approach to Smoking Related Interstitial Lung Disease Poster No.: C-1854 Congress: ECR 2013 Type: Educational Exhibit Authors: K.-N. Lee, J.-Y. Han, E.-J. Kang, J. Kang; Busan/KR Keywords: Toxicity,
More informationINHALED TREPROSTINIL IN PULMONARY HYPERTENSION DUE TO INTERSTITIAL LUNG DISEASE (PH-ILD)
THE INCREASE STUDY INHALED TREPROSTINIL IN PULMONARY HYPERTENSION DUE TO INTERSTITIAL LUNG DISEASE (PH-ILD) Peter Smith, PharmD Senior Director Product Development, United Therapeutics Corporation 2 SAFE
More informationDisclosures. Clinical Approach: Evaluating CTD-ILD for the pulmonologist. ILD in CTD. connective tissue disease or collagen vascular disease
Disclosures Clinical Approach: Evaluating CTD-ILD for the pulmonologist Industry relationships: Actelion, atyr Pharma, Boehringer-Ingelheim, Genentech- Roche, Gilead Aryeh Fischer, MD Associate Professor
More informationLUNG BIOPSY IN INTERSTITIAL LUNG DISEASE (ILD) AND THE IMPACT OF TRANSBRONCHIAL CRYOBIOPSY
LUNG BIOPSY IN INTERSTITIAL LUNG DISEASE (ILD) AND THE IMPACT OF TRANSBRONCHIAL CRYOBIOPSY Thomas V. Colby MD Professor of Pathology (Emeritus) Mayo Clinic College of Medicine FINANCIAL DISCLOSURES NONE
More informationCryptogenic Organizing Pneumonia Diagnosis Approach Based on a Clinical-Radiologic-Pathologic Consensus
Cryptogenic Organizing Pneumonia Diagnosis Approach Based on a Clinical-Radiologic-Pathologic Consensus Poster No.: C-1622 Congress: ECR 2012 Type: Scientific Exhibit Authors: C. Cordero Lares, E. Zorita
More informationUSEFULNESS OF HRCT IN DIAGNOSIS AND FOLLOW UP OF PULMONARY INVOLVEMENT IN SYSTEMIC SCLEROSIS
USEFULNESS OF HRCT IN DIAGNOSIS AND FOLLOW UP OF PULMONARY INVOLVEMENT IN SYSTEMIC SCLEROSIS Brestas P., Vergadis V., Emmanouil E., Malagari K. 2 nd Dept of Radiology, University of Athens, Greece ABSTRACT
More informationSupporting Information
Supporting Information Rock et al. 10.1073/pnas.1117988108 Fig. S1. Heterogeneity of stromal cells in normal and fibrotic mouse lungs. Sections of normal mouse lungs (A and D) and fibrotic lungs collected
More informationT he diagnostic evaluation of a patient with
546 REVIEW SERIES Challenges in pulmonary fibrosis? 1: Use of high resolution CT scanning of the lung for the evaluation of patients with idiopathic interstitial pneumonias Michael B Gotway, Michelle M
More information